METROLOTION Drug Patent Profile
✉ Email this page to a colleague
When do Metrolotion patents expire, and what generic alternatives are available?
Metrolotion is a drug marketed by Galderma Labs Lp and is included in one NDA.
The generic ingredient in METROLOTION is metronidazole. There are eighteen drug master file entries for this compound. Seventy suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metrolotion
A generic version of METROLOTION was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
Summary for METROLOTION
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 172 |
Patent Applications: | 3,915 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for METROLOTION |
What excipients (inactive ingredients) are in METROLOTION? | METROLOTION excipients list |
DailyMed Link: | METROLOTION at DailyMed |
Pharmacology for METROLOTION
Drug Class | Nitroimidazole Antimicrobial |
Anatomical Therapeutic Chemical (ATC) Classes for METROLOTION
US Patents and Regulatory Information for METROLOTION
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Galderma Labs Lp | METROLOTION | metronidazole | LOTION;TOPICAL | 020901-001 | Nov 24, 1998 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |